Virtual Investor Conferences announced the agenda for its Life Sciences Virtual Investor Forum on September 17, 2026, with eight companies scheduled to present. Avicanna CEO Aras Azadian will speak at 10:30 a.m. Eastern time in a live, interactive session where investors and industry professionals can submit questions. Participation and one-on-one meetings with company management are free, while a webcast replay will be available after the conference. Avicanna is a commercial-stage international biopharmaceutical company developing and commercializing cannabinoid-based products and formulations for medical and pharmaceutical markets. Its operations include the RHO Phyto medical cannabis formulary, the MyMedi.ca patient-care platform, a pharmaceutical pipeline and Aureus Santa Marta, its active pharmaceutical ingredients business.